Huang HW - Search Results

1

Preliminary study on 5-azacytidine anti-myeloma activity in vitro.

Chen GH, Wu DP, Lin FR, Wang Y, Huang HW, Chang HR. Chen GH, et al. Among authors: huang hw. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):602-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19549372

2

Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.

Chen G, Wang Y, Huang H, Lin F, Wu D, Sun A, Chang H, Feng Y. Chen G, et al. Eur J Haematol. 2009 Mar;82(3):176-83. doi: 10.1111/j.1600-0609.2008.01189.x. Epub 2008 Dec 5. Eur J Haematol. 2009. PMID: 19077051

3

Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid.

Huang H, Wu D, Fu J, Chen G. Huang H, et al. Leuk Lymphoma. 2009 Jun;50(6):966-73. doi: 10.1080/10428190902866724. Leuk Lymphoma. 2009. Retraction in: Leuk Lymphoma. 2014 Jun;55(6):1437. doi: 10.3109/10428194.2014.917821 PMID: 19373597 Retracted.

4

All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.

Huang H, Wu D, Fu J, Chen G, Chang W, Chow HC, Leung AY, Liang R. Huang H, et al. Eur J Haematol. 2009 Sep;83(3):191-202. doi: 10.1111/j.1600-0609.2009.01277.x. Epub 2009 May 8. Eur J Haematol. 2009. PMID: 19467017

5

[5-azacytidine treatment induces tumor suppressor gene XAF1 expression and inhibits proliferation in myeloma cells].

Chen GH, Lin FR, Wu DP, Wang Y, Huang HW, Tang XW, Zhu ZL, Feng YF, Chang WR. Chen GH, et al. Among authors: huang hw. Zhonghua Xue Ye Xue Za Zhi. 2009 Apr;30(4):229-32. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19731821 Chinese.

6

[Rosiglitazone and all-trans retinoic acid inhibit human myeloma cell proliferation via apoptosis signaling pathway modulation].

Huang HW, Wu DP, Chen GH, Chang HR, Chow HC, Leung AY, Liang R. Huang HW, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Apr;30(4):242-6. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19731824 Chinese.

7

[Advances of study on PPARgamma/PPARgamma ligand in hematologic malignancies].

Huang HW, Wu DP. Huang HW, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1592-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 20030954 Review. Chinese.

8

[Differentiating effect of PPARgamma ligand rosiglitazone and all trans-retinoic acid on myeloma cells and its possible mechanism].

Huang HW, Chen GH, Chang HR, Chow HC, Leung AY, Liang R, Wu DP. Huang HW, et al. Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):885-9. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20193324 Chinese.

9

[Establishment of murine allogeneic umbilical cord blood cell transplantation model and study on the mechanism of keratinocyte growth factor enhancing immune reconstitution after transplantation.].

Wang Y, Chen GH, Wu DP, Huang HW, Wang Y, Xu Y, Ma X, Sun AN, Chang HR. Wang Y, et al. Among authors: huang hw. Zhonghua Xue Ye Xue Za Zhi. 2010 Feb;31(2):82-7. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 20302793 Chinese.

10

Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.

Xu Y, Zhao Y, Huang H, Chen G, Wu X, Wang Y, Chang W, Zhu Z, Feng Y, Wu D. Xu Y, et al. Br J Haematol. 2010 Sep;150(5):543-53. doi: 10.1111/j.1365-2141.2010.08284.x. Epub 2010 Jul 14. Br J Haematol. 2010. PMID: 20629663 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters